Published • loading... • Updated
Pfizer (NYSE:PFE) trails S&P 500 as China GLP-1 watch puts yield in focus
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Pfizer (NYSE:PFE) trails S&P 500 as China GLP-1 watch puts yield in focus
New York, June 29, 2026, 18:06 (EDT) Pfizer Inc. (NYSE:PFE) ticked up 0.4% to $24.37 late Monday. The S&P 500 gained 1.18% in regular trading. (Reuters) Pfizer’s ecnoglutide and Innovent Biologics Inc. (HKG:1801) mazdutide both cleared an initial review in China for a spot on the country’s national medical insurance drug list, according to Reuters.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
